BioSpace News Archive

The Institute for Life Science Entrepreneurship (ILSE) at Kean University has created Biotech LaunchPad, a comprehensive suite of business and scientific services to support the commercial success of life science startups.

Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could be significant genetic transfer between bacteria in our ecosystems and to humans.

The artificial disc market is projected to observe noteworthy gains on account of rising prevalence of degenerative disc disease cases across both developing and developed economies.

Anivive, a pharmaceutical startup using software to develop novel therapeutics for pets, is delighted to announce that its first commercial product, LAVERDIA-CA1 (verdinexor), has been conditionally approved by the Food and Drug Administration (FDA).

The atrial fibrillation drugs market is forecasted to record lucrative growth on account of large presence of geriatric population base that is susceptible to valvular diseases.

Global prevalence of systemic and localized autoimmune disorders, emergence of various government initiatives and enhanced ability to spend on the treatment of these ailments will stimulate autoimmune disease diagnostics market trends.

Expert in Value-Based Contracting and Network Management Will Deepen Relationships With Payers, Providers, and Academic Centers

eMed™, a digital health company democratizing healthcare through digital point-of-care solutions, today announced a partnership with the State of Ohio to distribute and administer at least 2 million virtually-guided, BinaxNOW™ at-home COVID-19 rapid tests, which deliver results within minutes.

Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company has received the CE-IVD mark for its Advanta™ Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus. The CE-IVD mark is in conformance with the European Union In Vitro Diagnostic Directive. T

Adamis Pharmaceuticals Corporation announced that its SYMJEPI® Injection products are now available to members of the Walgreens Prescription Savings Club program, for a discounted price of $99.99 for a two-pack, the lowest price offered for epinephrine products through the Walgreens Prescriptions Savings Club, and the lowest price for epinephrine devices on the market1.